This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: University of Michigan. Active years: 2010-2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010-2013
Title: Dewayne Townsend: Innovator in Cardiovascular Treatments
Introduction
Dewayne Townsend is a notable inventor based in Ann Arbor, MI (US). He has made significant contributions to the field of cardiovascular health, particularly in the treatment and prevention of heart disease. With a total of 2 patents, Townsend's work focuses on innovative compositions and methods that aim to improve patient outcomes.
Latest Patents
Townsend's latest patents include compositions and methods for treating and preventing cardiomyopathy and heart disease. These inventions provide compositions comprising poloxamers, such as poloxamer 188 (P188), and outline methods for their use in treating heart disease, especially in subjects with muscular dystrophy. His work also addresses the treatment of cells and tissue damage caused by ischemia and cell death, specifically targeting dystrophin-deficient cells like myocytes.
Career Highlights
Throughout his career, Townsend has been associated with reputable institutions, including the University of Michigan. His innovative research has positioned him as a key figure in the development of therapeutic strategies for heart disease.
Collaborations
Some of his notable coworkers include Daniel E Michele and Joseph M Metzger, who have contributed to his research endeavors.
Conclusion
Dewayne Townsend's contributions to cardiovascular treatments through his patents reflect his commitment to advancing medical science. His innovative approaches hold promise for improving the lives of individuals affected by heart disease.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile